{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:53:42Z","timestamp":1769604822369,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.jinf.2005.04.020","type":"journal-article","created":{"date-parts":[[2005,6,6]],"date-time":"2005-06-06T16:56:10Z","timestamp":1118076970000},"page":"216-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Risk factors and outcome for nosocomial breakthrough candidaemia"],"prefix":"10.1016","volume":"52","author":[{"given":"A.C.","family":"Pasqualotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.L.","family":"Nedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.S.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.C.","family":"Severo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2005.04.020_bib1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/320757","article-title":"Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia","volume":"32","author":"Uzun","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.04.020_bib2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/514731","article-title":"Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"28","author":"Viscoli","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.04.020_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10096-002-0697-1","article-title":"Risk factors for breakthrough candidemia","volume":"21","author":"Nucci","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2005.04.020_bib4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-9343(95)00010-0","article-title":"The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance","volume":"100","author":"Nguyen","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.jinf.2005.04.020_bib5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/502104","article-title":"Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity","volume":"23","author":"Kontoyiannis","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2005.04.020_bib6","first-page":"378","article-title":"Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies","volume":"89","author":"Myoken","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.jinf.2005.04.020_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/jac\/41.3.373","article-title":"Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome","volume":"41","author":"Krcmery","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2005.04.020_bib8","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2005.04.020_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/S0036-46652004000500001","article-title":"Candidemia in a Brazilian tertiary care hospital: species distribution and antifungal susceptibility patterns","volume":"46","author":"Antunes","year":"2004","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.jinf.2005.04.020_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0002-9343(98)00030-8","article-title":"Predictors of adverse outcome in cancer patients with candidemia","volume":"104","author":"Anaissie","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.jinf.2005.04.020_bib11","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1086\/374894","article-title":"Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia","volume":"36","author":"Myoken","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.04.020_bib12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0895-4356(01)00372-9","article-title":"Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain","volume":"54","author":"Bagley","year":"2001","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305001180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445305001180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:29:09Z","timestamp":1758986949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445305001180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0163445305001180"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2005.04.020","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and outcome for nosocomial breakthrough candidaemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2005.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}